2023
DOI: 10.1089/neu.2021.0502
|View full text |Cite
|
Sign up to set email alerts
|

Microdialysis-Based Classifications of Abnormal Metabolic States after Traumatic Brain Injury: A Systematic Review of the Literature

Abstract: Thank you for taking the time to read and review our systematic review and provide feedback to improve our manuscript. We have addressed the comments raised regarding editing the language to improve readability. The revised version of the manuscript we are submitting incorporates these changes and we hope that you find this satisfactory.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 76 publications
0
4
0
Order By: Relevance
“…Measurement of P bt O 2 , CPP and arterial oxygen saturation has been used to guide treatment of cerebral hypoxia in severe TBI, helping to uncover physiologic states that may lead to impaired brain oxygen metabolism [ 115 ]. CMD-based parameters, including LPR and pH, can directly characterize cerebral metabolic states, including ischemia, metabolic stress, and mitochondrial dysfunction [ 107 , 124 ], and has been shown to predict cerebral metabolic crisis and disruptions in cerebral perfusion requiring therapeutic intervention [ 110 , 119 ]. The identification of metabolic derangement, including mitochondrial dysfunction via CMD-based MMM, has also been used to guide targeted metabolic treatment of TBI [ 111 ].…”
Section: Resultsmentioning
confidence: 99%
“…Measurement of P bt O 2 , CPP and arterial oxygen saturation has been used to guide treatment of cerebral hypoxia in severe TBI, helping to uncover physiologic states that may lead to impaired brain oxygen metabolism [ 115 ]. CMD-based parameters, including LPR and pH, can directly characterize cerebral metabolic states, including ischemia, metabolic stress, and mitochondrial dysfunction [ 107 , 124 ], and has been shown to predict cerebral metabolic crisis and disruptions in cerebral perfusion requiring therapeutic intervention [ 110 , 119 ]. The identification of metabolic derangement, including mitochondrial dysfunction via CMD-based MMM, has also been used to guide targeted metabolic treatment of TBI [ 111 ].…”
Section: Resultsmentioning
confidence: 99%
“…In vivo microdialysis has been applied in human subjects in areas such as brain tumors [ 45 ], traumatic brain injury [ 73 ], and stroke [ 14 ], however, exploratory biomarker research in humans using invasive techniques, such as in vivo microdialysis, is highly discouraged. For this purpose, a more plausible scientific approach is the use of animal models for direct investigation of ECF by in vivo microdialysis to find potential novel biomarkers or target molecules, which should be followed by human CSF and serum analysis for verification and translation.…”
Section: Discussionmentioning
confidence: 99%
“…We initiated an animal model study of brain tissue-related peptidome of the ECF to reveal cellular processes reflected in the dialysate. We note that microdialysis can also be performed in human subjects for monitoring extracellularly available molecules [ 14 , 73 ]. To validate the concept that brain cells release peptides in correlation with changes in cellular processes in physiological and pathological conditions, we selected an epilepsy model for the peptidome analysis.…”
Section: Introductionmentioning
confidence: 99%
“…The technique can also be used to determine the concentration of drugs in different brain tissues as well as changes in the concentration of non-binding drugs in the brain’s extracellular fluid over time. This technology has become indispensable in the study of brain-targeting drugs and their active pharmacological effects in the CNS, and it is suitable for in vivo biochemical and deep brain region research ( Venturini et al, 2023 ). However, this method has high instrument requirements and costs, and it is not conducive to large-scale experiments.…”
Section: Common Experimental Methods Used In Intranasal Drug Delivery...mentioning
confidence: 99%